Company Quick10K Filing
Innophos Holdings
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-02-27
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-07-31
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-02
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-10-31
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-02-19
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-30
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-10-30
10-Q 2013-06-30 Filed 2013-07-31
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-20
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-02
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-02
10-Q 2011-03-31 Filed 2011-05-04
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-03
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-08
8-K 2020-02-07
8-K 2020-01-22
8-K 2020-01-15
8-K 2019-11-06
8-K 2019-10-19
8-K 2019-08-06
8-K 2019-05-14
8-K 2019-04-30
8-K 2019-04-01
8-K 2019-03-15
8-K 2019-02-20
8-K 2018-11-19
8-K 2018-10-29
8-K 2018-10-16
8-K 2018-09-27
8-K 2018-07-30
8-K 2018-06-29
8-K 2018-05-15
8-K 2018-05-01
8-K 2018-04-02
8-K 2018-03-26
8-K 2018-02-21
8-K 2018-02-08

Innophos Holdings Financials

IPHS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash8180863561703727263236334338453657808618153933533033332941122320213231
Accounts Receivable868286104127989494110102998810710895911001011018092858078848510210110710910310311299106
Inventory114148158170150153154164140154158181165164164185176175170173167156139128137127149146154159169180174172170
PP&E189189188487184179186532197197202566201202200592197197197620199202203653206207212696221232232742237235238
Assets641662679687691686677739719729730745750738738728748753752670678672645643638632771785810801820815865870876
Accounts Payable3744383330413636464044393938435336494237433935524645607064706580555158
Long-Term Debt143142141959493921001501641589615113512492201240282882262251950189180295310345330345300330330340
Liabilities287292301294275258238295270274271282280261260265317368409336342332299296289281417452474466480480519531538
Stockholders' Equity353370378393416428439444449455459463470476478463431385342333336340345347348351354334336335341336347339338
Income Statement ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue198202202209228240211209214213220197216220209194202217200171190182186168166179184193205207197193191185189
Cost of Revenue140152153160172198168172177172181155174167158152161176162146149146145135129140143161163170162163155149157
Gross Profit5749495056424336374139424253514241413725413641333739413242363530363633
R&D1111111111121111111111111111111111
SG&A16161518171517151819171719221918181923271816181619202122232320192018
Tax1311119927986117-1261197663-12056456615944103
Net Income2621192128171713121211151424181112145-51312149111112-11116145916
Cash Flow ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating311530-2930442713683017333542172532123-3454057-11302734-41619-9268
Cash Investing-7-9-11-27-5-5-33-62-7-8-14-8-6-9-7-8-6-8-8-10-8-11-7-11-8-8-134-43-9-20-14-10-6-10
Cash Financing-7-6-1361-29-2851-296-12-13-17-31-29-1825-22-7-828-11-39-26-6-19106525-24620-91